tm logo
NKIRANT
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 24 Feb 2020

Last Applicant/ Owned by

4242 Campus Point Court, Suite 200

San Diego

CA

92121

Serial Number

87101610 filed on 12th Jul 2016

Registration Number

N/A

Correspondent Address

BETH M. GOLDMAN

ORRICK, HERRINGTON & SUTCLIFFE LLP

IP Prosecution Department

2050 Main Street, Suite 1100

IRVINE CA 92614-8255

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NKIRANT

Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy

Classification Information


Class [005]
Pharmaceutical Products


Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy

Mark Details


Serial Number

No 87101610

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 21539-6000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Feb 2020ABANDONMENT - NO USE STATEMENT FILED
24th Feb 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
17th Jul 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Jul 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
16th Jul 2019EXTENSION 5 GRANTED
11th Jul 2019TEAS EXTENSION RECEIVED
11th Jul 2019EXTENSION 5 FILED
25th Dec 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Dec 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
21st Dec 2018EXTENSION 4 FILED